CVS Health Corporation
CVS
$78.66
$0.110.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.66% | 6.21% | 4.75% | 3.93% | 5.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.66% | 6.21% | 4.75% | 3.93% | 5.96% |
| Cost of Revenue | 7.22% | 7.53% | 5.99% | 5.95% | 7.89% |
| Gross Profit | 3.13% | -1.67% | -2.54% | -7.56% | -4.69% |
| SG&A Expenses | 3.22% | 3.37% | 4.47% | 4.89% | 5.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.76% | 7.05% | 5.82% | 5.83% | 7.63% |
| Operating Income | 2.76% | -19.07% | -24.74% | -42.23% | -32.71% |
| Income Before Tax | -56.77% | -32.63% | -27.23% | -44.97% | -42.10% |
| Income Tax Expenses | 44.44% | -17.69% | -23.10% | -44.31% | -42.09% |
| Earnings from Continuing Operations | -91.46% | -37.69% | -28.65% | -45.20% | -42.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 583.33% | 400.00% | 224.14% | 216.67% | 128.57% |
| Net Income | -90.65% | -36.98% | -27.88% | -44.70% | -41.89% |
| EBIT | 2.76% | -19.07% | -24.74% | -42.23% | -32.71% |
| EBITDA | 2.03% | -13.22% | -17.56% | -30.99% | -23.56% |
| EPS Basic | -90.11% | -36.28% | -26.54% | -43.51% | -40.91% |
| Normalized Basic EPS | 10.48% | -13.20% | -19.45% | -39.94% | -33.59% |
| EPS Diluted | -90.29% | -36.30% | -26.40% | -43.35% | -40.69% |
| Normalized Diluted EPS | 10.62% | -13.09% | -19.32% | -39.85% | -33.49% |
| Average Basic Shares Outstanding | -0.16% | -0.90% | -1.62% | -2.08% | -1.94% |
| Average Diluted Shares Outstanding | -0.28% | -1.08% | -1.83% | -2.23% | -2.10% |
| Dividend Per Share | 2.31% | 4.72% | 7.26% | 9.92% | 9.94% |
| Payout Ratio | 9.94% | 0.65% | 0.46% | 0.95% | 0.86% |